Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:Putnam Facing 16 Suits Not Rated 0.0 Email Routing List Email & Route  Print Print
Friday, November 14, 2003

Putnam Facing 16 Suits

by: Nicole Halsey

Settling yesterday with the SEC was apparently not enough to satisfy Putnam Investment’s investors. In a filing with the SEC, Marsh & McLennan Cos. disclosed that Putnam Investments face 16 class action suits related to the mutual-fund trading scandal, the Wall Street Journal reports.

The company also said that as of November 12, 2003, it and Putnam had been named in two director shareholder suits; one a shareholder derivative action naming Marsh and its directors and another naming Marsh, Putnam and members of the Putnam board of trustee. Another purported ERISA action names Marsh, Putnam and others related to the company.

Also, Secretary of the Massachusetts Secretary of the Commonwealth William Galvin has keep his promise to pursue Putnam despite the SEC settlement. Marsh & McLennan announced that the subpoena Putnam received from the United States Attorney in New York has been withdrawn and replaced with a subpoena from the United States Attorney in Boston, "inquiring into, among other things, matters that are the subject of the SEC and Massachusetts actions."  

Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

0.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2024: Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly




©All rights reserved to InvestmentWires, Inc. 1997-2024
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use